González-González, Alberto
Álvarez-Iglesias, Itziar
García-Sánchez, Daniel
Dotta, Monica
Reyes, Ricardo
Alfonso-Fernández, Ana
Bolado-Carrancio, Alfonso
Díaz-Rodríguez, Patricia
Pérez-Núñez, María Isabel
Rodríguez-Rey, José Carlos
Delgado-Calle, Jesús
Pérez-Campo, Flor M. https://orcid.org/0000-0002-9872-7990
Funding for this research was provided by:
Ministerio de Economía y Competitividad (PID2021-127493OB-C21)
Instituto de Salud Carlos III (PI22/0264)
Instituto de Investigación Marqués de Valdecilla (PREVAL19/02, PREVAL 20/01, NEXT-VAL)
National Institute of Health (R37-CA251763, R01-CA209882)
Article History
Received: 25 October 2024
Accepted: 21 January 2025
First Online: 7 February 2025
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki. This study was approved by the Institutional Bioethics Committee of the University of Cantabria (Reference 2015/21; Project Title: Enhancing Mesenchymal Stem Cells Osteogenic Capacity Through Modulation of the Bone Marrow Microenvironment; date of approval 04–11-22) and the Consejería de Agricultura y Ganadería de Cantabria (Reference PI-08–21; Project Title: Modulation of the Regenerative Capacity of Mesenchymal Stem Cells for Their Use in Therapies Applied to the Musculoskeletal System; date of approval 01–11-21). Bone samples were obtained from the patients after anonymization. Informed consent was obtained from all the subjects involved in the study.
: Not applicable.
: The authors declare that they have no competing interests.